Equity

Tatva Chintan Pharma Chem Ltd announced credit rating upgrades from CRISIL Ratings Limited, with the Long Term rating upgraded to CRISIL A-/Stable from CRISIL BBB+/Stable and the Short Term rating upgraded to CRISIL A2+ from CRISIL A2; the ratings reflect Fund-Based Facilities (Citibank N. A.) amounting to 85 Crore with a rating of CRISIL A-/Stable, Fund-Based Facilities (State Bank of India) amounting to 40 Crore with a rating of CRISIL A-/Stable, Fund-Based Facilities (ICICI Bank Limited) amounting to 60 Crore with a rating of CRISIL A-/Stable, Fund-Based Facilities (DBS Bank Limited) amounting to 35 Crore with a rating of CRISIL A-/Stable, a Letter of Credit & Bank Guarantee (ICICI Bank Limited) of 5.5 Crore with a rating of CRISIL A2+, a Letter of Credit & Bank Guarantee (State Bank of India) of 5 Crore with a rating of CRISIL A2+, and a Proposed Term Loan of 14.5 Crore with a rating of CRISIL A-/Stable, with no rating actions or withdrawals noted for any of the listed instruments.